Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots — study

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those

1/26/2022 1:00:00 AM

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac’s CoronaVac shot, a study has found.

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those

The study found that CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants, researchers fromBrazil and Oxford University saidon Monday.China-based Sinovac’s vaccine uses an inactivated version of a coronavirus strain that was isolated from a patient in China. It is currently approved in more than 50 countries including Brazil, China, Argentina, South Africa, Oman, Malaysia, Indonesia and Turkey.

“This study provides important options for policymakers in the many countries where inactivated vaccines … have been used,” said Andrew Pollard, director of the Oxford Vaccine Group and study lead.However, another study in December found that Sinovac’s two-dose shot followed by a booster dose of Pfizer-BioNTech’s vaccine showed a lower immune response against the Omicron variant compared with other strains.

Read more: Interaksyon »

Sputnik V COVID-19 vaccine recipients retain more antibodies vs. Omicron —studyA study by Russian and Italian scientists showed that those who received a shot of the Sputnik V COVID-19 vaccine retained more antibodies against the Omicron coronavirus variant as compared to those who received a dose of the Pfizer COVID-19 vaccine. Then why are Russians refusing to take it. sputnik supremacy 🤘🤘🤘🤘

Samsam in isolation after family gets COVID-19Talisay City Mayor Gerald Anthony ‘Samsam’ Gullas announced that he will be working from home after his family tested positive of COVID-19.

Nadine Samonte’s family, including one-month-old baby Harmony, gets COVID-19Nadine Samonte’s family was also among those who contracted COVID-19 after New Year.

What's inside Imus' COVID-19 kit? City gov't says molnupiravir, antibiotics prescription-only medsSome doctors earlier questioned the need to include Merck's COVID-19 oral pill molnupiravir and other prescription drugs in Imus City, Cavite's COVID-19

Halal COVID-19 vaccines should be arranged amid hesitancy in Mindanao —NTF adviserNational Task Force Against COVID-19 medical adviser Dr. Ted Herbosa on Tuesday said COVID-19 vaccines that are halal should be arranged for people who prefer this. May halong baboy pa pala yung mga naiturok na Covid vaccines

Pharmacy vaccinations to expand to Baguio, other areasThe government's program to administer booster shots in pharmacies will be expanded to Baguio City and other areas, presidential adviser for COVID-19 response Vince Dizon said on Monday.

who have previously received two doses of Sinovac’s CoronaVac shot, a study has found. The study found that CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants, researchers from Brazil and Oxford University said on Monday. China-based Sinovac’s vaccine uses an inactivated version of a coronavirus strain that was isolated from a patient in China. It is currently approved in more than 50 countries including Brazil, China, Argentina, South Africa, Oman, Malaysia, Indonesia and Turkey. “This study provides important options for policymakers in the many countries where inactivated vaccines … have been used,” said Andrew Pollard, director of the Oxford Vaccine Group and study lead. However, another study in December found that Sinovac’s two-dose shot followed by a booster dose of Pfizer-BioNTech’s vaccine showed a lower immune response against the Omicron variant compared with other strains. Viral vector vaccines such as the ones developed by AstraZeneca-Oxford and J&J use a weakened version of another virus to deliver genetic instructions for making proteins from the virus against which protection is sought. Pfizer and BioNTech’s mRNA vaccines deliver a genetic transcript with instructions for making viral proteins to teach the body how to defend against infections. A third dose of CoronaVac also increased antibodies, but the results were better when a different vaccine was used, according to the latest study that included 1,240 volunteers from the Brazilian cities of Sao Paulo and Salvador. Antibody levels were low before the booster doses, with only 20.4% of adults aged 18-60 and 8.9% of adults aged over 60 having detectable levels of neutralizing antibodies. These were seen to significantly increase across every booster vaccine regimen, according to the study, which in the Lancet medical journal on Friday. —Reporting by Aby Jose Koilparambil and Pushkala Aripaka in Bengaluru; Editing by Ramakrishnan M.